Literature DB >> 27646067

[Imaging in structural heart disease : Impact on interventional therapy].

A Schmermund1, J Eckert2, S N Schelle2, H Eggebrecht2.   

Abstract

For the treatment of structural heart disease, current options in the catheterization laboratory include MitraClip® implantation for treating severe mitral regurgitation, transcatheter aortic valve implantation (TAVI), closure of a patent foramen ovale (PFO) and occlusion of the left atrial appendage (LAA). These treatment options are based on a precise diagnosis provided by modern cardiac imaging, which is indispensable for treatment recommendations. Its importance for supporting the invasive procedures in the catheterization laboratory is less well known. Due to enhanced soft tissue characterization, it complements fluoroscopy and invasive angiography and thus enormously improves the safety of the procedures. In addition, it allows individualized follow-up care. The current article gives an overview of the clinically most frequently used procedures.

Entities:  

Keywords:  Aortic valve stenosis; Cardiac imaging; Echocardiography; Mitral valve insufficiency; Peri-interventional

Mesh:

Year:  2016        PMID: 27646067     DOI: 10.1007/s00059-016-4481-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  27 in total

1.  Differential left ventricular outflow tract remodeling and dynamics in aortic stenosis.

Authors:  Praveen Mehrotra; Aidan W Flynn; Katrijn Jansen; Timothy C Tan; Gary Mak; Howard M Julien; Xin Zeng; Michael H Picard; Jonathan J Passeri; Judy Hung
Journal:  J Am Soc Echocardiogr       Date:  2015-08-22       Impact factor: 5.251

2.  [Current recommendations on echocardiographic evaluation of the severity of mitral regurgitation: standardization and practical application using a scoring system].

Authors:  Thomas Buck; Björn Plicht; Raimund Erbel
Journal:  Herz       Date:  2006-02       Impact factor: 1.443

3.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-08-01       Impact factor: 24.094

4.  Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.

Authors:  Rebecca T Hahn; Theodore Abraham; Mark S Adams; Charles J Bruce; Kathryn E Glas; Roberto M Lang; Scott T Reeves; Jack S Shanewise; Samuel C Siu; William Stewart; Michael H Picard
Journal:  J Am Soc Echocardiogr       Date:  2013-09       Impact factor: 5.251

5.  Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial.

Authors:  Seth Uretsky; Linda Gillam; Roberto Lang; Farooq A Chaudhry; Edgar Argulian; Azhar Supariwala; Srinivasa Gurram; Kavya Jain; Marjorie Subero; James J Jang; Randy Cohen; Steven D Wolff
Journal:  J Am Coll Cardiol       Date:  2015-03-24       Impact factor: 24.094

6.  The association of patent foramen ovale morphology and stroke size in patients with paradoxical embolism.

Authors:  Andre Akhondi; Rubine Gevorgyan; Chi-Hong Tseng; Leo Slavin; Catherine Dao; David S Liebeskind; Jonathan M Tobis
Journal:  Circ Cardiovasc Interv       Date:  2010-09-21       Impact factor: 6.546

Review 7.  Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography.

Authors:  Nina C Wunderlich; Roy Beigel; Martin J Swaans; Siew Yen Ho; Robert J Siegel
Journal:  JACC Cardiovasc Imaging       Date:  2015-04

8.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

9.  Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.

Authors:  Howard C Herrmann; Philippe Pibarot; Irene Hueter; Zachary M Gertz; William J Stewart; Samir Kapadia; E Murat Tuzcu; Vasilis Babaliaros; Vinod Thourani; Wilson Y Szeto; Joseph E Bavaria; Susheel Kodali; Rebecca T Hahn; Mathew Williams; D Craig Miller; Pamela S Douglas; Martin B Leon
Journal:  Circulation       Date:  2013-05-09       Impact factor: 29.690

10.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

View more
  1 in total

1.  [Cardioband®: Where do we stand, who are suitable patients?]

Authors:  C Frerker; T Schmidt; R Pfister; M I Körber; V Mauri; M Wösten; S Baldus
Journal:  Herz       Date:  2019-11       Impact factor: 1.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.